Vietnam has decided to incorporate Health Technology Assessment (HTA) evidence to support reimbursement decisions for medicines and has recognised the need for standard guidelines for both the process and the methodological aspects of HTA. The Health Strategy and Policy Institute (HSPI), Ministry o

Summary of the HTAsiaLink 2018  In 2018, was co-hosted by the Health Intervention and Technology Assessment Program (HITAP) and the Health Technology Assessment Program at Mahidol University from 8-11 May 2018 in Chiang Mai, Thailand. The theme of the conference was “Testing Treatments: Strengthe

This report summarizes the study visit of delegates from the National Health Insurance Authority (NHIA), Ghana to the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand between 28 October and 1 November 2024.   The report has been prepared by Dr. Brandon Chua and M

With the introduction of the Universal Health Coverage (UHC) in Asian countries, priority-setting and HTA has become increasingly important.  However, only in the past decade has HTA been used to inform countries’ health programs and policies. As such, HTA agencies are relatively new in Asia.  In 20

Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki

Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program. Tantivess S1 Teerawattananon Y1 Mills A1 1 Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand 2 London

As a part of Memorandum of Understanding (MoU) on healthcare between the Kenyan Ministry of Health and Thai Ministry of Public Health, a delegation from Kenya, including the Senate, Health Financing Reforms Experts’ Panel (HEFREP), and Ministry of Health of Kenya, visit Thailand from 5th to 7th June

Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions.   The

MEAs aim at early access to high-cost innovative medicines at pre-determined terms that can ensure the financial sustainability of healthcare systems. However, their successful adoption hinges on a consideration of various factors to address the unique challenges faced by different nations. The a

The Standard Cost List for Health Technology Assessment in Thailand provides the foundational cost data for Health Technology Assessment (HTA) and economic evaluation studies. It supplies robust, context-specific cost data to inform evidence-based policy, specifically for developing and revising benefit packages under Thailand’s Universal Coverag